AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Aquis Exchange Plc

Regulatory Filings Feb 5, 2021

6169_rns_2021-02-05_a59cc935-8adc-47e2-a216-74a50eec9b1f.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 1867O

Aquis Exchange PLC

05 February 2021

5 February 2021

Aquis Exchange PLC

("Aquis" or the "Company")

Appointment of Joint Broker

Aquis Exchange PLC (AQX.L), the exchange services group, is pleased to announce the appointment of Canaccord Genuity Limited as Joint Broker to the Company with immediate effect.

Liberum Capital Ltd remains Nominated Adviser and Joint Broker to the Company.

Alasdair Haynes, CEO, Aquis Exchange, said:

"We are very pleased to welcome Canaccord Genuity as our joint corporate broker. Canaccord brings strong institutional reach both domestically and internationally. Our focus continues to be on executing our growth strategy with our goal to become one of the leading exchange services groups through delivering best-in-class exchange trading opportunities, underpinned by our commitment to first class client service."

- Ends -

Enquiries:

Aquis Exchange PLC Tel: +44 (0) 20 3597 6321
Alasdair Haynes, CEO
Jonathan Clelland, CFO and COO
Belinda Keheyan, Head of Marketing +44 (0) 7768 078 110
Liberum Capital Limited (Nominated Adviser and Joint Broker) Tel: +44 (0) 20 3100 2000
Clayton Bush
Chris Clarke
Edward Thomas
Kane Collings
Canaccord Genuity Limited (Joint Broker) Tel: +44 (0) 20 7523 8000
Emma Gabriel (Corporate Broking)

Jeremy Grime (Specialist Sales)
Alma PR (Financial PR Adviser) Tel: +44 (0)20 3405 0209
Susie Hudson

Caroline Forde
[email protected]
Kieran Breheny

Faye Calow

Notes to editors:

Aquis Exchange PLC is an exchange services group, which operates pan-European cash equities trading businesses (Aquis Exchange), growth and regulated primary markets (Aquis Stock Exchange/AQSE) and develops/licenses exchange software to third parties (Aquis Technologies).

Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority and France's Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK and in EU27 respectively. Aquis operates a lit order book and does not allow aggressive non-client proprietary trading, which has resulted in lower toxicity and signalling risk on Aquis than other trading venues in Europe. According to independent studies, trades on Aquis are less likely to lead to price movement than on other lit markets. Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue.

Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.

Aquis Exchange PLC (AQX.L) is listed on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to www.aquis.eu

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

APPLELFBFLLBBBE

Talk to a Data Expert

Have a question? We'll get back to you promptly.